{
  "docId": "019de075-e1f8-726f-9315-81fdfad7abab",
  "docSlug": "b23275bc2e690ecf91711f5f1c92fd3d",
  "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 37 slides",
  "authorId": "aeglea-biotherapeutics",
  "authorName": "Spyre Therapeutics",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-10-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 19,
  "pageCount": 37,
  "prevPage": 18,
  "nextPage": 20,
  "slideType": "executive_summary",
  "function": "summarize",
  "density": "balanced",
  "nDataPoints": 0,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de075-e1f8-726f-9315-81fdfad7abab/19",
  "deckHref": "/decks/019de075-e1f8-726f-9315-81fdfad7abab",
  "deckJsonHref": "/decks/019de075-e1f8-726f-9315-81fdfad7abab.json",
  "deckAnchorHref": "/decks/019de075-e1f8-726f-9315-81fdfad7abab#slide-19",
  "components": [
    {
      "bbox": {
        "h": 0.38,
        "w": 0.53,
        "x": 0.235,
        "y": 0.308
      },
      "kind": "image",
      "text": null,
      "attrs": null,
      "subkind": "icon-grid",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d2efa70f-815e-4d62-b1cf-d67469143c6b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.052,
        "w": 0.234,
        "x": 0.13,
        "y": 0.465
      },
      "kind": "list",
      "text": "COMPARABLE IN VITRO PERFORMANCE TO VEDOLIZUMAB",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6d446502-8234-418f-9a98-0765324d4944",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.038,
        "w": 0.234,
        "x": 0.654,
        "y": 0.465
      },
      "kind": "list",
      "text": "INTERIM PHASE 1 PK DATA EXPECTED YE2024",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9947ed25-6747-485f-bc6c-d6bf8a8046bc",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.066,
        "w": 0.234,
        "x": 0.392,
        "y": 0.451
      },
      "kind": "list",
      "text": "PK MODELLING SUPPORTS Q8-12W SC DOSING; UPSIDE POTENTIAL FOR GREATER INDUCTION EFFICACY",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c0ab844a-b1a1-45bc-bf47-b2031d308ef4",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.094,
        "w": 0.288,
        "x": 0.026,
        "y": 0.044
      },
      "kind": "title",
      "text": "SPY001 summary",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9c9e93cf-2471-4ea4-8953-999c739fcff0",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Executive summary",
      "slug": "executive-summary",
      "agent": null,
      "layer": "slide",
      "matchId": "2cac6813-4e56-4919-9e33-0386957b8f50",
      "evidence": "The slide is titled 'SPY001 summary' and contains a list/bullet points summarizing key information",
      "confidence": 0.9
    }
  ],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 19,
      "from": 6,
      "beatId": "68c6fca4-e8f4-4ede-b0dc-880b8c41a146",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Solution",
      "beatSlug": "sequoia-pitch-solution",
      "evidence": "The document presents a detailed solution, including SPY001 and SPY002, from pages 6 to 19",
      "position": 1,
      "confidence": 0.8,
      "parentBeatName": "Turn",
      "parentBeatSlug": "turn"
    }
  ],
  "loops": [
    {
      "to": 19,
      "from": 6,
      "name": "Golden Circle",
      "slug": "11-golden-circle",
      "bestFor": "Visionary leadership, brand positioning, mission statements",
      "matchId": "0f2e25ea-e3dc-4c15-9e23-1d88590fd563",
      "evidence": "The solution section presents a clear 'why' for Spyre's approach",
      "position": 1,
      "objective": "Why does Spyre's approach make sense?",
      "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
      "confidence": 0.7,
      "description": "Invert the typical pitch by starting with why you exist, rather than what you do"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}